Evidence map›Paper›PMID 32746724›Full record

ArticlePhlebology2020

Response to letter to editor regarding: "Risks and contraindications of medical compression treatment - a critical reappraisal. An international consensus statement PHLEB-19-150.R1".

Eberhard Rabe, Hugo Partsch, Nick Morrison, Mark H Meissner, Giovanni Mosti, Christopher R Lattimer, Patrick H Carpentier, Sylvain Gaillard, Michael Juenger, Tomasz Urbanek and 6 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Phlebology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Eberhard RabeDepartment of Dermatology, University of Bonn, Bonn, Germany.ORCID 0000-0002-2436-7697
Hugo PartschDepartment of Dermatology, 27271Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-9476-7381
Nick MorrisonCenter for Vein Restoration, Mesa, AZ, USA.ORCID 0000-0002-1750-6521
Mark H MeissnerDepartment of Surgery, Harborview Medical Center, Seattle, WA, USA.
Giovanni MostiAngiology Department, Clinica MD Barbantini, Lucca, Italy.ORCID 0000-0001-7639-8463
Christopher R LattimerJosef Pflug Vascular Laboratory, West London Vascular and Interventional Centre, Ealing Hospital & Imperial College, London, UK.ORCID 0000-0002-0282-4826
Patrick H CarpentierCentre de Recherche Universitaire de La Léchère, Equipe THEMAS, Université Joseph Fourier, Grenoble, France.
Sylvain GaillardSIGVARIS Management AG, Winterthur, Switzerland.
Michael JuengerDepartment of Dermatology, University of Greifswald, Greifswald, Germany.
Tomasz UrbanekDepartment of General Surgery, Vascular Surgery, Angiology and Phlebology, Medical University of Silesia, Katowice, Poland.
Juerg HafnerDepartment of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
Malay PatelFirst Choice Vascular, Swastik Society, Ahmedabad, India.
Stephanie WuDepartment of Podiatric Surgery & Applied Biomechanics, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
Joseph CapriniDepartment of Vascular Surgery, The University of Chicago, Chicago, IL, USA.
Fedor LurieDepartment of Vascular Surgery, University of Michigan, Ann Arbor, MI, USA.
Tobias HirschPractice for Internal Medicine and Vascular Diseases, Halle, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ContraindicationsConsensus Statements as TopicHumans

Identifiers

PMID32746724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.